BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 years.
covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale manufacturing, and quality control down to sterile ...
The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.
The company’s Woodstock, Illinois facility will receive a new automated, high-speed bottle packaging line, expanding its BFS ...
Our offerings in small molecule, generic APIs and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill-finish capabilities. Our scientific and ...
WOODSTOCK, Ill., March 11, 2025 (GLOBE NEWSWIRE) -- Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), is expanding its BFS ...
Our offerings in small molecule, generic APIs and biologics span discovery through commercialization, with integrated regulatory, analytical and sterile fill-finish capabilities. Our scientific ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results